April L. Risinger
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Oncology top 5%
- Cell Biology top 5%
- Pharmacology top 5%
- Co-authors
- Susan L. MooberryFrancis J. GilesNicholas F. Dybdal‐HargreavesLin DuJiangnan PengChris A. KaiserRobert H. CichewiczJing Li
- Topics
- Microtubule and mitosis dynamics (27 papers)Cancer Treatment and Pharmacology (21 papers)Phytochemical Studies and Bioactivities (17 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyNature Communications
- Partner nations
- United StatesEgyptSpain
In The Last Decade
April L. Risinger
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 1.1k
- Organic Chemistry 515
- Oncology 491
- Cell Biology 413
- Pharmacology 244
Countries citing papers authored by April L. Risinger
This map shows the geographic impact of April L. Risinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April L. Risinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April L. Risinger more than expected).
Fields of papers citing papers by April L. Risinger
This network shows the impact of papers produced by April L. Risinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April L. Risinger. The network helps show where April L. Risinger may publish in the future.
Co-authorship network of co-authors of April L. Risinger
This figure shows the co-authorship network connecting the top 25 collaborators of April L. Risinger. A scholar is included among the top collaborators of April L. Risinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April L. Risinger. April L. Risinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 4 | |
| 9 | 10 | |
| 10 | 23 | |
| 11 | 5 | |
| 12 | 42 | |
| 13 | 7 | |
| 14 | 28 | |
| 15 | 25 | |
| 16 | 31 | |
| 17 | 111 | |
| 18 | 44 | |
| 19 | 47 | |
| 20 | 29 |
About April L. Risinger
April L. Risinger is a scholar working on Cell Biology, Oncology and Pharmacology, having authored 78 papers that have together received 1.8k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (27 papers), Cancer Treatment and Pharmacology (21 papers) and Phytochemical Studies and Bioactivities (17 papers). The work is most often cited by research in Cell Biology (413 citations), Toxicology (63 citations) and Organic Chemistry (515 citations). April L. Risinger has collaborated with scholars based in United States, Egypt and Spain. Frequent co-authors include Susan L. Mooberry, Francis J. Giles, Nicholas F. Dybdal‐Hargreaves, Lin Du, Jiangnan Peng, Chris A. Kaiser, Robert H. Cichewicz, Jing Li, Evelyn M. Jackson and Gregory L. Helms. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.